Back to Subject Index | Return to Arthritis & Rheumatism Table of Contents Page

N-acetylglucosamine, carbohydrate in RA immune complexes and, 744
Naive mice
bone marrow cell transplantation in antiphospholipid syndrome, 115
IL-1 in experimental arthritis in, 164
Naproxen, gastrointestinal tract and, 5
National Arthritis Data Work Group, cost and impact of musculoskeletal conditions and, 1351
National Health Interview Survey, cost and impact of musculoskeletal conditions and, 1351
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), rheumatology and, 451
Native American studies, geographic clusters of SLE, 1564
Native 3-B-3 mimotopes, monoclonal antibodies in detection of biochemical markers of arthritis and, 655
Native 52-kd SS-A/Ro, autoepitopes of, 990
Native DR molecules, p4 peptide pocket binding to DRB1*0401 and, 1744
Native low-density lipoprotein, cross-reactivity of anticardiolipin autoantibodies with, 1382
Native proteins, HRES-1 antibodies and, in SLE and overlap syndromes, 1660
Natural antibodies, autoimmunity and, 301
Natural killer cells, immunosuppressive drugs during pregnancy and, 1722
Natural nuclear proteins, Mi-2 autoantigen in DM and, 1389
Nausea, in refractory RA, 1177, 1187, 1589
N-carbosyalkyl synthetic matrix metalloproteinase inhibitor, L-696,418, stromelysin degradation of cartilage and, 1678
Neck, in cutaneous LE from ultraviolet emissions from a photocopier, 1152
Necrolysis, toxic epidermal, after sulfasalazine in psoriatic arthritis, 573
Necrosis
avascular, 655, 1218
caseous, loosening of revision total hip replacement in RA and, 1315
Necrotizing granulomas, total knee prosthesis and, 1325
Necrotizing vasculitis, peripheral neuropathy with, in RA, 1618
Neoepitope, stromelysin-cleaved rabbit aggrecan and, 1400
Neonatal immune neutropenia, IgG receptors in autoimmune disease and, 306
Neoplasia, colorectal, NSAID, gastrointestinal tract and, 5
Neoplastic T cells, carpal tunnel syndrome due to T cell lymphoma and, 1707
Nephritis
acute interstitial, renal biopsy in RA and, 242
glomerulonephritis and C4 deficiency, 1333
lupus, 1722, 1832
Nephritogenic anti-DNA antibodies NE-1 and NE-14, IgM, DNA binding of IgM[gl] anti-DNA antibodies and, 389
Nephrotic syndrome, in RA and amyloidosis, after azathioprine, 1851
Nerves, in peripheral neuropathy with necrotizing vasculitis in RA, 1618
Nervous system involvement, cognitive deficit in rheumatic diseases and, 1363
Neural substrate, cognitive deficit in rheumatic diseases and, 1363
Neuroendothelial system, in Raynaud's phenomenon and scleroderma, 1
Neuroimaging, cognitive deficit in rheumatic diseases and, 1363
Neurologic involvement
cognitive deficit in rheumatic diseases and, 1363
enteroviral RNA, bacterial DNA and, in juvenile DM, 1513
spin-spin relaxation of brain in SLE and, 810
in walking velocity in elderly, 343
Neuromuscular abnormalities
cognitive deficit in rheumatic diseases and, 1363
degenerative lumbar spinal stenosis and, 1236
Neuronal calcitonin gene-related peptide-like immunoreactivity, in rat adjuvant arthritis, 699
Neuronal protein, Lyme borreliosis and, 565
Neuropathy
cognitive deficit in rheumatic diseases and, 1363
multifocal, 1618
noncompressive, 1618
peripheral, with necrotizing vasculitis in RA, 1618
sensory, 1618
Neuropeptides
in Raynaud's phenomenon and scleroderma, 1
substance P and calcitonin gene-related peptide in rat adjuvant arthritis, 699
Neuropsychiatric lupus, spin-spin relaxation of brain in SLE and, 810
Neutral phospholipids, human monoclonal antiphospholipid antibody and, 1068
Neutropenia
large granular lymphocytes in hematology of Felty's syndrome and, 1242
neonatal immune, IgG receptors and, 306
Neutrophils
antineutrophil cytoplasmic antibodies and, 1375, 1855
circulating primed, in pulmonary capillaritis, 1855
cytokines, early response genes and, 877
IgG receptors in autoimmune disease and, 306
large granular lymphocytes in hematology of Felty's syndrome and, 1242
lipoxin A4, nitric oxide and, in polymorphonuclear neutrophil vascular cytotoxicity, 768
peripheral blood, in Behcet's disease, 426
protease, rheumatoid synovial fibroblast adhesion to cartilage and, 1694
(New Zealand white [times] BXSB)F1 mice, cross-reactivity of anticardiolipin autoantibodies with oxidized low-density lipoprotein, 1382
New Zealand white rabbit studies
CPPD synovitis in OA in, 201
stromelysin degradation of cartilage, 1678
Newborn infants, immunosuppressive drugs during pregnancy and, 1722
19-kd urease Yersinia, guidelines for medical management of OA and, 1547
92-kd gelatinase B, Arg-Gly-Asp (RGD) peptide and IL-1 in chondrocyte matrix metalloproteinase synthesis and, 1304
Nitric oxide
lipoxin A4 and, in polymorphonuclear neutrophil vascular cytotoxicity, 768
synthase, in articular chondrocytes in the pathogenesis of arthritic swelling, 1529
Nomenclature, polyglot, polymorphism and, 1715
Nonadherent cell fractions, RF B cells, IL-10 and, in RA, 1771
Noncompressive neuropathies, peripheral neuropathy with necrotizing vasculitis in RA and, 1618
Noncutaneous T cell lymphoma, carpal tunnel syndrome due to, 1707
Non-Hodgkin's lymphoma, mixed cryoglobulinemia and, 1859
Nonobese diabetes, autoimmune disease induction by microbial pathogens and, 458
Non-opioid analgesics, guidelines for medical management of OA and, 1535, 1541
Non-rapid eye movement, sleep electroencephalography, amitriptyline and, in fibromyalgia, 1211
Nonsteroidal antiinflammatory drugs (NSAID)
in Chinese herbal medications, 614
draft guidelines for, in JRA clinical trials, 715
gastroduodenal injury in children induced by, 1225
gastrointestinal tract and, 5
guidelines for medical management of OA and, 1535, 1541
hypothalamic-pituitary-adrenal axis and, 723
in RA, 1107, 1447
sulfasalazine in spondylarthropathy and, 618
vitamin B6 in rheumatoid cachexia and, 105
Nontransgenic mice, peripheral blood neutrophils in Behcet's disease and, 426
Northern blotting
in OA, 413, 420
to study complement in RA, 492
to study IL-1 receptor antagonist in SLE, 1055
to study Mi-2 autoantigen in DM, 1389
nRNP, autoimmune response to the spliceosome and, 777
N-terminal, in stromelysin degradation of cartilage, 173
Nuclear antigens, proliferating cell, in activation markers of RA synovial membrane, 1346
Nuclear factor-κB, in rheumatoid synovium, 1762
Nuclear proteins
HRES-1 antibodies and, in SLE and overlap syndromes, 1660
Mi-2 autoantigen in DM and, 1389
Nuclear RNP, small, anti-U1 RNA antibodies in connective tissue disease and, 1837
Nucleolar organizer regions, in activation markers of RA synovial membrane, 1346
Nucleosome-restricted antibodies, in SLE, 1485
Nucleotides
adenine, antiinflammatory effects of adenosine regulators and, 1040
DNA binding of IgM[gl] anti-DNA antibody and, 389
human monoclonal antiphospholipid antibody and, 1068
Nuclepore Hemafil PC membranes, erythrocytes in rheumatoid vasculitis and, 248
(NZB [times] BXSB)F1 mice, cross-reactivity of anticardiolipin autoantibodies with oxidized low-density lipoprotein, 1382